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INTRODUCTION
A desmoid tumour, also called aggressive fibromatosis, 
is a benign tumour originating from musculoaponeurotic 
structures throughout the body. The tumour can behave 
aggressively and infiltrate adjacent soft tissue structures or 
recur locally (1). Surgery, radiation therapy, and chemotherapy 
have been used to treat extra-abdominal desmoid tumours. 
However, their effectiveness is limited by frequent local 
recurrences (1, 2). This article describes our experience 
using a CT-guided steroid injection to treat a chest wall 
desmoid tumour. This is the first report of a CT-guided 
steroid injection for the treatment of a desmoid tumour.
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We report on a 41-year-old woman with a chest wall desmoid tumour who was successfully treated with a computed 
tomography (CT)-guided steroid injection. She presented with a palpable mass in the right upper chest wall and was treated 
by surgical excision and postoperative radiation therapy due to recurrence of the mass at the surgical site. At 20 months 
after the second operation, a recurrent mass was again detected in the anterosuperior portion of the previous surgical site 
on CT. We performed a CT-guided steroid injection weekly for 4 weeks by applying a mixture of 3 mL of triamcinolone 
acetonide (40 mg/mL) and 3 mL of 1% Lidocaine, administering 4-6 mL of the mixture, to the lesion. Six months later, CT 
showed a marked decrease in the size of the mass.
Index terms: Desmoid tumor; CT; Steroid; Chest wall
Received June 10, 2011; accepted after revision August 23, 2011.
Corresponding author: Sang Hyun Paik, MD, Department of 
Radiology, Soonchunhyang University Hospital Bucheon, 170 
Jomaru-ro, Wonmi-gu, Bucheon 420-767, Korea. 
• Tel: (8232) 621-5853 • Fax: (8232) 621-5874
• E-mail: radpsh@schmc.ac.kr
This is an Open Access article distributed under the terms of 
the Creative Commons Attribution Non-Commercial License 
(http://creativecommons.org/licenses/by-nc/3.0) which permits 
unrestricted non-commercial use, distribution, and reproduction in 
any medium, provided the original work is properly cited. 
Case Report
Korean J Radiol 2012;13(3):342-344
CASE REPORT
A 41-year-old woman presented with a palpable mass in 
the right upper chest wall. A chest radiograph showed a 
round, soft-tissue density in the right upper hemithorax. 
Axial CT was obtained along with a 16-channel multi-
detector CT (Sensation 16, Siemens Medical Solutions, 
Forchheim, Germany) with contrast enhancement. A round, 
2.4 x 6-cm, isodense mass with enhancement surrounded 
the anterior arc of the right second rib. There was no 
evidence of cortical disruption, periosteal reaction, or bony 
erosion (Fig. 1A). The mass was excised and found to be an 
extra-abdominal fibromatosis.
One year later, she returned with right shoulder pain. 
Contrast-enhanced CT showed a 6 x 4-cm homogenously 
enhancing mass at the previous surgical site with cortical 
disruption at the anterior arc of the right first and 
second ribs (Fig. 1B). It was excised and the pathologic 
diagnosis was extra-abdominal fibromatosis (desmoid-type 
fibromatosis), with extension to adjacent skeletal muscle 
and bone. She was treated with postoperative radiation 
therapy, at a dose of 5000 cGY.
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Recurrent Chest Wall Desmoid Treated with CT-Guided Steroid Injection
She underwent follow-up radiographs every three months 
in the thoracic surgery outpatient department. At 20 months 
after the second operation, an approximately 3.5 x 3.2 x 
3.2-cm sized heterogeneously enhancing mass was detected 
in the anterosuperior portion of the previous surgical site 
on CT examination (Fig. 1C, D). A CT-guided biopsy revealed 
recurrent desmoid-type fibromatosis.
We performed weekly CT-guided steroid injections for four 
weeks. All injections were performed using a conventional 
spiral CT scanner (HiSpeed; GE Medical Systems, Milwaukee, 
WI, USA). First, the patient underwent imaging in the 
supine position with a section thickness of 5 mm with 
no contrast enhancement. Then, the skin was prepared 
in a sterile fashion, and 1% Lidocaine hydrochloride was 
administered with a 25-gauge hypodermic needle to 
anesthetise the skin and subcutaneous tissue. We used the 
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Fig. 1. Recurrent chest wall desmoid tumor in 41-year-old woman.
A. Contrast enhanced axial CT image shows round, 2.4 x 6-cm enhancing mass surrounded by anterior arc of right second rib. B. Contrast 
enhanced axial CT image shows 6 x 4-cm homogeneously enhancing mass at previous surgical site with cortical disruption at anterior arc of 
right first and second ribs. C, D. Contrast enhanced axial CT and coronal reconstruction images show 3.5 x 3.2 x 3.2-cm recurrent mass in 
anterosuperior portion of previous surgical site with heterogeneous enhancement. E, F. Axial CT image shows injection needle located in center 
of mass and CT image after injection. G, H. Follow-up chest axial CT and coronal reconstruction images after 6 months show marked decrease in 
size of mass.Korean J Radiol 13(3), May/Jun 2012 kjronline.org 344
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coaxial technique with an 18-gauge needle and a 22gauge 
percutaneous ethanol injection therapy (PEIT) needle with 
multiple side holes (Hakko Medical, Nagano, Japan) to 
effectively inject the steroid. The mass was targeted using 
an 18-gauge needle using the coaxial technique, while the 
needle alignment was monitored by CT. The guide needle 
was anchored through the space between the right clavicle 
and anterior arc of the first rib. After anchoring, the axial 
CT was performed to confirm the adequacy of the position 
of the needle tip (Fig. 1E, F). We prepared a mixture of 3 
mL of triamcinolone acetonide (40 mg/mL) and 3 mL of 1% 
Lidocaine. The mixture was injected using a 22gauge PEIT 
needle with multiple side holes, twice. The total volume 
injected was 4-6 mL. We repeated the CT-guided injection 
every week with the same dose of 46 mL of the mixture.
After three months, she underwent axial and coronal CT, 
but there was no interval change in the size of the recurrent 
mass. A CT examination 6 months later showed a marked 
decrease in the size of the mass (Fig. 1G, H), from 3.5 x 3.2 
x 3.2 cm to 3.0 x 2.8 x 1.5 cm.
DISCUSSION
Desmoids also are known as aggressive fibromatosis. 
These tumours are histologically benign, but may behave 
aggressively at the local level, with multiple recurrences 
being common. In the management of desmoid tumours, 
treatment options include surgical resection, radiotherapy, 
anti-inflammatory agents, hormonal therapy, and 
chemotherapy. Wide excision is the treatment of choice for 
lesions that are relatively small and favourably located. 
However, the effectiveness of surgical resection is limited 
by the frequent local recurrence. Local recurrence rates after 
surgical excision are approximately 50% in patients older 
than 20 years (3). If a wide excision cannot be achieved 
without functional loss, radiation therapy is a treatment 
option. However, radiotherapy has a relapse rate of 31% for 
unresectable tumours (4).
Because of the infiltrative and recurring nature of 
the lesion in our patient, re-operation could not be the 
treatment of choice. Considering the presence of pain 
and continued rapid growth of the lesion, some type of 
intervention is suggested. Intralesional steroid injection 
is the most effective and widely used treatment for 
keloids. Triamcinolone acetonide is the most commonly 
used corticosteroid. Typically, 10 mg per linear centimetre 
of keloid is injected every 26 weeks. Triamcinolone 
reduces fibroblast proliferation and collagen synthesis, 
increases collagenase production, and reduces the levels 
of collagenase inhibitors as well as suppress inflammatory 
mediators and glycosaminoglycan synthesis (5, 6). On the 
basis of the knowledge that a desmoid tumor is composed 
of the proliferation of fibroblast and myofibroblast, as well 
as dense deposits of intracellular collagen fiber, we believe 
that a trial of intralesional corticosteroids could arrest the 
growth of desmoid tumor.
To our knowledge, this is the first report describing the 
treatment of recurrent desmoid tumours using a steroid 
injection.
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